Pfizer, Inc. (PFE)

lepant (92.10) Submitted: 5/15/08 10:32 PM : Start Price: $20.12 PFE Score: 4.99

Basing this pick on article found in the ASCO abstract, specifically located here http://www.abstract.asco.org/AbstView_55_31007.htm. Basically this particular abstract is about the possible use of Celecoxib (marketed and sold by Pfizer under the brand name Celebrex) as a possible preventive treatment for lung cancer. This study along with other I managed to locate indicate it was effective in that regard. Leading to possible off label or maybe even possible FDA labeling as an intended use, the first studies were released about a year ago so this information might already be priced in, but it's a shot worth taking in my opinion.

Report this Post Replies: 0 | Reply